Evofem Biosciences Announces 1-for-15 Reverse Stock Split

SAN DIEGO, May 5, 2022 /PRNewswire/ — Evofem Biosciences, Inc., (Nasdaq: EVFM) (the “Company”) today announced that the Board and stockholders of the Company approved a 1-for-15 reverse stock split of the Company’s common stock at the annual meeting of the Company held on May 4, 2022….

Click here to view original post